# FDA recall D-0052-2018

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2017-10-17.

## Product

Methylphenidate Hydrochloride Tablets USP, 20 mg, 100-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA  92880 USA, NDC 0591-5884-01.

## Reason for recall

Failed Dissolution Specifications: Low out of specification results for dissolution.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0052-2018
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-10-17
- **Report date:** 2017-11-01
- **Termination date:** 2018-04-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0052-2018

## Citation

> AI Analytics. FDA recall D-0052-2018. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0052-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*